Pattern of regional metastases and prognostic factors in differentiated thyroid carcinoma

被引:0
|
作者
Spriano, G. [1 ]
Ruscito, P. [1 ]
Pellini, R. [1 ]
Appetecchia, M. [2 ]
Roselli, R. [1 ]
机构
[1] Regina Elena Inst Canc Res, Dept Otolaryngol Head & Neck Surg, Rome, Italy
[2] Regina Elena Inst Canc Res, Endocrinol Unit, Rome, Italy
关键词
Thyroid carcinoma; Nodal metastases; Extra-capsular spread; LYMPH-NODE METASTASIS; NECK DISSECTION; CANCER; THERAPY; IMPACT;
D O I
暂无
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
The meaning of nodal metastases in well-differentiated thyroid carcinoma is controversial. The Authors analyse the impact of lymphatic spread reviewing 1503 cases of well-differentiated thyroid carcinoma treated at the National Cancer Institute of Rome between 1988 and 2005, in order to detect significant prognostic factors through multivariate analysis. Overall, 462 cases of locally advanced well-differentiated thyroid carcinoma, were considered. A multivariate analysis of a subgroup, comprising 97 N+ consecutive cases of well-differentiated thyroid carcinoma, previously untreated, was performed to study prognostic factors for local (N+) and distant (M+) metastasis in well-differentiated thyroid carcinoma. Of the 97 cases, 88 were submitted to surgery for a large well-differentiated thyroid carcinoma, 9 for occult differentiated thyroid carcinoma. After surgery, 12 patients were lost to follow-up, 8 resulted pathologically negative, therefore only 77 cases of pN1 well-differentiated thyroid carcinoma were studied. Considering all cases of well-differentiated thyroid carcinoma, 10-year-overall survival was 58.7% for locally advanced well-differentiated thyroid carcinoma, compared to 94.8% in low stage cases. Neck dissection, margin infiltration and extra-capsular spread were significant prognostic factors. The Authors present a retrospective study of 77 patients with primary differentiated thyroid carcinoma, submitted to thyroidectomy and neck dissection aimed at analysing distribution of nodal metastases according to Robbins' levels classification and defining their prognostic value. All N1b cases, retrospectively reviewed (n. 77), presented clinical and histological evidence of neck nodes metastases from differentiated thyroid carcinoma; histological reports indicated tumour localisation and topographical distribution of metastases; papillary carcinoma was the most common type (72 cases), followed by follicular carcinoma (5 cases). Surgical treatment always comprised total thyroidectomy and 6(th) level dissection. Overall 52 cases were submitted to monolateral neck dissection, 25 to bilateral neck dissection. Treatment of the lateral neck was postero-lateral neck dissection (n. 53), selective lateral neck dissection (n. 20), modified radical and radical (n. 29). Cervical level IV was the most frequently involved (52%), extra-capsular spread of metastases was identified in 22% of the cases. Statistically significant prognostic factors for distant metastases and recurrence on the neck were follicular carcinoma (p < 0.01) and extra-capsular spread (p < 0.001). Age, pT, sex, number of positive nodal metastases, T-extension and the number of nodal positive levels were not significant. In the Authors' experience, histological grade of differentiation, wide tumour excision and neck dissection, in cases of N1b well-differentiated thyroid carcinoma, without residual disease (R1, R2), in the central and lateral neck, are determinant prognostic factors. Extracapsular spread in particular, was found to be a highly predictive factor either of distant metastasis or regional recurrence.
引用
收藏
页码:312 / 316
页数:5
相关论文
共 50 条
  • [31] Bone metastases from differentiated thyroid carcinoma
    Muresan, M. M.
    Olivier, P.
    Leclere, J.
    Sirveaux, F.
    Brunaud, L.
    Klein, M.
    Zarnegar, R.
    Weryha, G.
    [J]. ENDOCRINE-RELATED CANCER, 2008, 15 (01) : 37 - 49
  • [32] MANAGEMENT OF INTRACRANIAL METASTASES OF DIFFERENTIATED CARCINOMA OF THYROID
    BISWAL, BM
    BAL, CS
    SANDHU, MS
    PADHY, AK
    RATH, GK
    [J]. JOURNAL OF NEURO-ONCOLOGY, 1994, 22 (01) : 77 - 81
  • [33] Lung metastases from differentiated thyroid carcinoma
    Ronga, G
    Filesi, M
    Montesano, T
    Di Nicola, AD
    Pace, C
    Travascio, L
    Ventroni, G
    Antonaci, A
    Vestri, AR
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 48 (01): : 12 - 19
  • [34] Miliary lung metastases of differentiated thyroid carcinoma
    Taleb, S.
    Cherkaoui, G.
    Guensi, A.
    Kebbou, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S504 - S504
  • [35] Differentiated Thyroid Microcarcinoma: Prognostic factors
    Boudriga, H.
    El Fekih, H.
    Ben Fredj, M.
    Ben Rejeb, M.
    Sfar, R.
    Nouira, M.
    Chatti, K.
    Ajmi, S.
    Guezguez, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S609 - S609
  • [36] REGIONAL LYMPH-NODE METASTASES IN WELL-DIFFERENTIATED THYROID-CARCINOMA
    NOGUCHI, M
    YAMADA, H
    OHTA, N
    ISHIDA, T
    TAJIRI, K
    FUJII, H
    MIYAZAKI, I
    [J]. INTERNATIONAL SURGERY, 1987, 72 (02) : 100 - 103
  • [37] Nodal metastases and lymphadenectomy in differentiated thyroid carcinoma
    Gemsenjäger, E
    Heitz, PU
    Martina, B
    Schweizer, I
    [J]. CHIRURG, 2002, 73 (01): : 38 - 43
  • [38] Differentiated thyroid carcinoma with distant metastases: probability of survival and its predicting factors
    Mihailovic, J.
    Stefanovic, L.
    Malesevic, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S160 - S160
  • [39] Differentiated thyroid carcinoma patients with distant metastases: outcome of disease and influencing factors
    Mihailovic, J.
    Stefanovic, L.
    Malesevic, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S139 - S139
  • [40] Differentiated thyroid carcinoma with distant metastases: Probability of survival and its predicting factors
    Mihailovic, Jasna
    Stefanovic, Ljubomir
    Malesevic, Milica
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2007, 22 (02) : 250 - 255